We are live on ! Find out more
AQR Capital Management

AQR Capital Management Portfolio holdings

AUM $218B
1-Year Est. Return 29.41%
This Fund
S&P 500
This Quarter Est. Return
-13.32%
1 Year Est. Return
+29.41%
3 Year Est. Return
+92.15%
5 Year Est. Return
+116.61%
10 Year Est. Return
+435.72%
AUM
$86.3B
AUM Growth
-$18.2B
Cap. Flow
-$2.03B
Cap. Flow %
-2.36%
Top 10 Hldgs %
12.71%
Holding
2,392
New
138
Increased
818
Reduced
1,174
Closed
217

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$354M
2
VZ icon
Verizon
VZ
+$307M
3
HCA icon
HCA Healthcare
HCA
+$256M
4
MPC icon
Marathon Petroleum
MPC
+$239M
5
CMCSA icon
Comcast
CMCSA
+$231M

Sector Composition

Rank Sector Weight
1 Healthcare 20.11%
2 Technology 18.25%
3 Consumer Discretionary 14.02%
4 Industrials 10.23%
5 Financials 9.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NE
2051
DELISTED
Noble Corporation
NE
$220K ﹤0.01%
84,132
-85,307
-50% -$405K
TACO
2052
DELISTED
Del Taco Restaurants, Inc. Common Stock
TACO
$219K ﹤0.01%
21,890
-84,108
-79% -$907K
PETQ
2053
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
$217K ﹤0.01%
+9,253
New +$285K
LAB icon
2054
Standard BioTools
LAB
$314M
$216K ﹤0.01%
+25,111
New +$196K
DCPH
2055
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
$216K ﹤0.01%
+10,312
New +$254K
CAMP
2056
DELISTED
CalAmp Corp.
CAMP
$216K ﹤0.01%
722
+345
+92% +$143K
MSBI icon
2057
Midland States Bancorp
MSBI
$695M
$215K ﹤0.01%
9,609
-2,619
-21% -$68.3K
HTO
2058
H2O America
HTO
$2.62B
$214K ﹤0.01%
3,853
-18,430
-83% -$1.09M
CHTR icon
2059
Charter Communications
CHTR
$18.2B
$213K ﹤0.01%
+749
New +$235K
SYRE icon
2060
Spyre Therapeutics
SYRE
$9.25B
$212K ﹤0.01%
1,132
CCF
2061
DELISTED
Chase Corporation
CCF
$210K ﹤0.01%
2,095
-2,046
-49% -$220K
ECOM
2062
DELISTED
CHANNELADVISOR CORPORATION
ECOM
$209K ﹤0.01%
18,430
-21,316
-54% -$239K
PIR
2063
DELISTED
Pier 1 Imports, Inc.
PIR
$209K ﹤0.01%
34,176
-4,972
-13% -$136K
CKH
2064
DELISTED
Seacor Holdings Inc.
CKH
$209K ﹤0.01%
5,645
-1,383
-20% -$61.1K
VHI icon
2065
Valhi
VHI
$450M
$208K ﹤0.01%
9,000
-45,298
-83% -$1.14M
LDOS icon
2066
Leidos
LDOS
$17.3B
$207K ﹤0.01%
3,921
-102,654
-96% -$6.38M
TTPH
2067
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$207K ﹤0.01%
+9,167
New +$358K
USCR
2068
DELISTED
U S Concrete, Inc.
USCR
$206K ﹤0.01%
5,830
-1,036
-15% -$37.5K
NVTR
2069
DELISTED
Nuvectra Corporation Common Stock
NVTR
$206K ﹤0.01%
12,584
+100
+0.8% +$1.91K
CAR icon
2070
Avis
CAR
$5.02B
$205K ﹤0.01%
9,130
-134,466
-94% -$3.9M
HZO icon
2071
MarineMax
HZO
$788M
$204K ﹤0.01%
+11,153
New +$232K
NFBK
2072
DELISTED
Northfield Bancorp
NFBK
$204K ﹤0.01%
15,026
-1,170
-7% -$16.2K
ZLAB icon
2073
Zai Lab
ZLAB
$2.62B
$204K ﹤0.01%
+8,780
New +$163K
TWNK
2074
DELISTED
Hostess Brands, Inc. Class A Common Stock
TWNK
$204K ﹤0.01%
18,650
-4,541
-20% -$49.9K
BFYT
2075
DELISTED
Benefytt Technologies, Inc. Class A Common Stock
BFYT
$204K ﹤0.01%
7,644
-16,556
-68% -$664K

Similar funds

AQR Capital Management's Q4 2018 Portfolio in Review

As of Q4 2018, AQR Capital Management held 2,392 positions worth $86.3B, down 17% from $105B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

AQR Capital Management's Q4 2018 filing shows 138 new, 818 increased, 1,174 reduced and 217 closed positions. Its largest new stake was Linde: 705,153 shares worth $111M. The largest sale was Intel, an estimated $361M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 17% a quarter earlier, followed by Technology and Consumer Discretionary.

  • AQR Capital Management's largest Q4 2018 buy was Linde: 705,153 shares worth $111M.
  • AQR Capital Management added most to Merck in Q4 2018, an estimated $354M increase.
  • AQR Capital Management's biggest Q4 2018 reduction was Intel, cutting an estimated $361M.
  • AQR Capital Management fully exited Aetna Inc in Q4 2018, selling an estimated $104M.
  • AQR Capital Management's ten largest holdings make up 13% of its $86.3B portfolio in Q4 2018.
  • AQR Capital Management opened 138 new positions and closed 217 in Q4 2018.
  • AQR Capital Management's portfolio value fell 17% quarter-over-quarter to $86.3B.

Based on AQR Capital Management's 13F filing for Q4 2018, filed 14 Feb 2019.